Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly affect » significantly affected (Expand Search), significant effect (Expand Search), significant effects (Expand Search)
affect decrease » effects decreased (Expand Search), largest decrease (Expand Search)
Showing 2,361 - 2,380 results of 21,342 for search '(( significant decrease decrease ) OR ( significantly affect decrease ))', query time: 0.46s Refine Results
  1. 2361
    ZLN005 and metformin cell toxicity.

    ZLN005 and metformin cell toxicity. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2362
    ZLN005 increases PGC-1α and TFAM expression.

    ZLN005 increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2363
    ZLN005 and metformin toxicity in MAC.

    ZLN005 and metformin toxicity in MAC. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2364
    Full Western blot images from manuscript.

    Full Western blot images from manuscript. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2365
    Metformin rescues PGC-1α expression in presence of inhibitor.

    Metformin rescues PGC-1α expression in presence of inhibitor. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2366
    Metformin increases PGC-1α and TFAM expression.

    Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2367
    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α.

    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2368
    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.

    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2369
    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB.

    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2370
    NTM infection induces mitochondrial damage and reduces mitochondria number.

    NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2371
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2372
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 2373
    Average proportion of first choice female applicants stratified by specialty category.

    Average proportion of first choice female applicants stratified by specialty category. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2374
    Flowchart of patient selection in this study.

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 2375
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 2376
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2377
    Gender differences in first choice match outcomes.

    Gender differences in first choice match outcomes. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2378
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 2379
    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole.

    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 2380
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: